ARCHIVES

Fisher and Redmond Subject Of Misconduct Investigation; ORI

This article is from The Cancer Letter archive.

Vol. 20 No. 18 | May 6, 1994

Download PDF Visit The Full Archive

Related Articles

Executive Branch Should Improve Science Pay, NAS Says

July 16, 1993

Largest Oncological Society Exerts Clout, Getting Results

June 24, 1983

Program Announcements For Studies On Blue Collar Workers, Children Released By DRCCA

November 5, 1982

Three Institutes To Test BioMicro’s Microarray Product. GlycoDesign Allowed Patent For Cancer Drug GD0039.

March 1, 2002

ASCO Advises KRAS Testing In Patients With Metastatic Colorectal Cancer

January 30, 2009

Seattle Institutions Win $16 Million In Grants For Comparative Effectiveness Research

October 16, 2009